Celldex Therapeutics buy melinda
Start price
25.10.18
/
50%
€5.01
Target price
22.01.19
€5.55
Performance (%)
-10.27%
End price
22.01.19
€4.49
Summary
This prediction ended on 22.01.19 with a price of €4.49. The prediction for Celldex Therapeutics disappointed with a performance of -10.27%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Celldex Therapeutics | 11.842% | 11.842% | -1.734% | 32.605% |
| iShares Core DAX® | -1.816% | -2.419% | 12.070% | 14.356% |
| iShares Nasdaq 100 | 4.333% | 8.073% | 32.493% | 59.393% |
| iShares Nikkei 225® | 0.657% | 1.234% | 2.682% | 5.342% |
| iShares S&P 500 | 2.968% | 4.613% | 26.496% | 49.719% |
Comments by melinda for this prediction
In the thread Celldex Therapeutics diskutieren
SecteurRecherche biotechnologique et médicale Agenda 06/11 Publication de résultats
Develops and commercialization of immunotherapy technologies for the treatment of cancer and other diseases
Celldex Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products.
Its portfolio includes therapeutic antibodies, antibody drug conjugates, vaccines, and immune system modulators.
The company's drug candidates include Glembatumumab vedotin, Varlilumab, CDX-1401, CDX-301, and Rintega.
Celldex Therapeutics was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.
Celldex Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products.
Its portfolio includes therapeutic antibodies, antibody drug conjugates, vaccines, and immune system modulators.
The company's drug candidates include Glembatumumab vedotin, Varlilumab, CDX-1401, CDX-301, and Rintega.
Celldex Therapeutics was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.
Nombre d'employés : 197 personnes.
(Vom Mitglied beendet)
Stopped prediction by melinda for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€5.30
17.02.19
17.02.19
€9.02
30.10.19
30.10.19
-59.46%
30.10.19
30.10.19
Celldex Therapeutics
Start price
Target price
Perf. (%)
€31.52
16.02.18
16.02.18
€40.59
19.03.18
19.03.18
6.44%
19.03.18
19.03.18
Celldex Therapeutics
Start price
Target price
Perf. (%)
€36.75
22.09.17
22.09.17
€41.25
25.09.17
25.09.17
12.49%
25.09.17
25.09.17
Celldex Therapeutics
Start price
Target price
Perf. (%)
€33.15
22.09.17
22.09.17
€37.21
25.09.17
25.09.17
12.49%
25.09.17
25.09.17
Celldex Therapeutics
Start price
Target price
Perf. (%)
€65.08
07.04.16
07.04.16
€110.81
07.10.16
07.10.16
-12.68%
07.10.16
07.10.16
Celldex Therapeutics
Start price
Target price
Perf. (%)
€154.08
12.04.14
12.04.14
€187.50
13.10.14
13.10.14
-3.10%
13.10.14
13.10.14
Celldex Therapeutics
Start price
Target price
Perf. (%)
€176.42
13.06.13
13.06.13
€195.00
13.12.13
13.12.13
37.48%
13.12.13
13.12.13
Celldex Therapeutics
Start price
Target price
Perf. (%)
€44.55
03.10.10
03.10.10
€58.50
04.04.11
04.04.11
-5.25%
04.04.11
04.04.11